Advertisement

Organisation › Details
Thermosome GmbH
Thermosome is a clinical-stage drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a novel, proprietary tumor targeting approach that allows for significantly increased local drug concentrations and improved tumor penetration to achieve improved clinical treatment efficacy. The first clinical indication for its lead drug candidate THE001 is soft tissue sarcoma, where the Company aims to improve the current standard of care (free doxorubicin). Thermosome’s approach enables targeted tumor treatment independent of specific molecular targets and covers patient populations across all tumor subtypes. *
![]() |
Start | 2010-12-17 established (s-off) |
Predecessor | Max Planck Institute for Biophysical Chemistry (MPI-BPC) (Goettingen) | |
![]() |
Industry | TSL technology (thermosensitive nano drug encapsulation technology) |
Industry 2 | THE001 (DPPG2-TSL-DOX; thermosensitive liposomal formulation of doxorubicin) | |
![]() |
Person | Schweizer, Pascal (Thermosome GmbH 201604 Managing Director + Co-Founder) |
Person 2 | Schwandner, Wolfgang (Arnika Beteiligungen 201703 Managing Director) | |
![]() |
Region | Martinsried |
Country | Germany | |
Street | 19 Am Klopferspitz IZB Martinsried | |
City | 82152 Martinsried | |
Tel | +49-89-7167760-31 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Thermosome GmbH. (6/20/23). "Press Release: Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment". Munich. | ||
Record changed: 2024-12-29 |
Advertisement

More documents for Thermosome GmbH
- [1] Thermosome GmbH. (9/19/23). "Press Release: Thermosome Establishes High-Profile Clinical Advisory Board". Munich....
- [2] High-Tech Gründerfonds Management GmbH. (7/14/23). "Press Release: Pioneering Research Projects at the 8th Life Science Pitch Day at the IZB". Martinsried....
- [3] Thermosome GmbH. (6/20/23). "Press Release: Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment". Munich....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top